Aspirin therapy in diabetes mellitus

被引：0
|
作者：
Colwell, JA
机构：
来源：
DIABETOLOGIA | 1997年 / 40卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：867 / 867
页数：1
相关论文
共 50 条
  • [41] Aspirin for primary prevention of cardiovascular disease in diabetes mellitus
    Pignone, Michael
    Williams, Craig D.
    NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (11) : 619 - 628
  • [42] Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus
    Athanasakis, G.
    Papazafiropoulou, A.
    ARCHIVES OF HELLENIC MEDICINE, 2022, 39 (01): : 17 - 23
  • [43] TREATMENT OF CANINE SPONTANEOUS DIABETES-MELLITUS WITH ASPIRIN
    WAITZMAN, MB
    CORNELIUS, LM
    EVATT, BL
    METABOLIC AND PEDIATRIC OPHTHALMOLOGY, 1980, 4 (03) : 151 - 154
  • [44] Aspirin resistance in patients with type II diabetes mellitus
    Tasdemir, Eyyup
    Toptas, Tayfur
    Demir, Cengiz
    Esen, Ramazan
    Atmaca, Murat
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2014, 119 (01) : 25 - 31
  • [45] Resistance to Aspirin and Thienopyridines in Diabetes Mellitus and Metabolic Syndrome
    Anfossi, Giovanni
    Russo, Isabella
    Trovati, Mariella
    CURRENT VASCULAR PHARMACOLOGY, 2008, 6 (04) : 313 - 328
  • [46] Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
    Bowman, Louise
    Mafham, Marion
    Wallendszus, Karl
    Stevens, Will
    Buck, Georgina
    Barton, Jill
    Murphy, Kevin
    Aung, Theingi
    Haynes, Richard
    Cox, Jolyon
    Murawska, Aleksandra
    Young, Allen
    Lay, Michael
    Chen, Fang
    Sammons, Emily
    Waters, Emma
    Adler, Amanda
    Bodansky, Jonathan
    Farmer, Andrew
    McPherson, Roger
    Neil, Andrew
    Simpson, David
    Peto, Richard
    Baigent, Colin
    Collins, Rory
    Parish, Sarah
    Armitage, Jane
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (16): : 1529 - 1539
  • [47] Prevention of cardiovascular complications in diabetes mellitus: the role of aspirin
    Strizhakov, L. A.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2012, (02): : 94 - 99
  • [48] PHARMACODYNAMIC EFFECTS OF DIFFERENT TICAGRELOR MAINTENANCE DOSING REGIMENS WITH AND WITHOUT ASPIRIN IN PATIENTS WITH DIABETES MELLITUS: THE OPTIMUS (OPTIMIZING ANTIPLATELET THERAPY IN DIABETES MELLITUS)-7 STUDY
    Franchi, Francesco
    Rolini, Fabiana
    Paz, Luis Ortega
    Been, Latonya
    Al Saleh, Tala
    Durukan, Selina
    Uzunoglu, Ekin Can
    Rivas, Andrea
    Farahmandsadr, Maryam
    Mahowald, Madeline
    Suryadevara, Siva
    Choi, Calvin Y.
    Soffer, Daniel
    Zenni II, Martin M.
    Angiolilo, Dominick J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (12)
  • [49] GLIBENCLAMIDE THERAPY IN DIABETES MELLITUS
    BHATIA, SK
    HADDEN, DR
    MONTGOMERY, DA
    WEAVER, JA
    BMJ-BRITISH MEDICAL JOURNAL, 1970, 2 (5709): : 570 - +
  • [50] Cell therapy for diabetes mellitus
    Kobayashi, Naoya
    CELL TRANSPLANTATION, 2006, 15 (10) : 849 - 854
12345